These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2557 related items for PubMed ID: 22334135

  • 1. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [Abstract] [Full Text] [Related]

  • 2. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E, Soydal C, Kucuk ON, Ibis E, Erbay G.
    Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
    [Abstract] [Full Text] [Related]

  • 3. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P.
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [Abstract] [Full Text] [Related]

  • 4. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS, Shahin MA.
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [Abstract] [Full Text] [Related]

  • 5. The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.
    Aukema TS, Rutgers EJ, Vogel WV, Teertstra HJ, Oldenburg HS, Vrancken Peeters MT, Wesseling J, Russell NS, Valdés Olmos RA.
    Eur J Surg Oncol; 2010 Apr; 36(4):387-92. PubMed ID: 19962268
    [Abstract] [Full Text] [Related]

  • 6. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
    Sharma P, Jain TK, Singh H, Suman SK, Faizi NA, Kumar R, Bal C, Malhotra A, Kumar R.
    Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886
    [Abstract] [Full Text] [Related]

  • 7. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 8. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS.
    PLoS One; 2014 Jun; 9(12):e115127. PubMed ID: 25517451
    [Abstract] [Full Text] [Related]

  • 9. Role of 18F-FDG PET/CT in detecting recurrent gallbladder carcinoma.
    Kumar R, Sharma P, Kumari A, Halanaik D, Malhotra A.
    Clin Nucl Med; 2012 May; 37(5):431-5. PubMed ID: 22475890
    [Abstract] [Full Text] [Related]

  • 10. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
    Yi JS, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY, Roh JL.
    J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
    [Abstract] [Full Text] [Related]

  • 11. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
    Dennis K, Hay JH, Wilson DC.
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
    [Abstract] [Full Text] [Related]

  • 12. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
    Majhail NS, Urbain JL, Albani JM, Kanvinde MH, Rice TW, Novick AC, Mekhail TM, Olencki TE, Elson P, Bukowski RM.
    J Clin Oncol; 2003 Nov 01; 21(21):3995-4000. PubMed ID: 14581422
    [Abstract] [Full Text] [Related]

  • 13. FDG-PET/CT in the diagnosis of recurrent breast cancer.
    Murakami R, Kumita S, Yoshida T, Ishihara K, Kiriyama T, Hakozaki K, Yanagihara K, Iida S, Tsuchiya S.
    Acta Radiol; 2012 Feb 01; 53(1):12-6. PubMed ID: 22067206
    [Abstract] [Full Text] [Related]

  • 14. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
    Park JW, Jo MK, Lee HM.
    BJU Int; 2009 Mar 01; 103(5):615-9. PubMed ID: 19007371
    [Abstract] [Full Text] [Related]

  • 15. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY, Lee CH, Seo MJ, Lee SH, Ryu JS, Lee JJ.
    Ann Nucl Med; 2014 Oct 01; 28(8):789-95. PubMed ID: 24965850
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients.
    Jung NY, Yoo IR, Kang BJ, Kim SH, Chae BJ, Seo YY.
    Breast Cancer; 2016 Jan 01; 23(1):141-148. PubMed ID: 24872087
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma.
    Sharma P, Jain S, Karunanithi S, Pal S, Julka PK, Thulkar S, Malhotra A, Bal C, Kumar R.
    Eur J Nucl Med Mol Imaging; 2014 Jun 01; 41(6):1084-92. PubMed ID: 24435775
    [Abstract] [Full Text] [Related]

  • 18. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X, Wu F, Han P.
    Hell J Nucl Med; 2014 Jun 01; 17(3):177-83. PubMed ID: 25526754
    [Abstract] [Full Text] [Related]

  • 19. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
    Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T.
    Indian J Med Res; 2018 Mar 01; 147(3):256-262. PubMed ID: 29923514
    [Abstract] [Full Text] [Related]

  • 20. The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification.
    Cochet A, David S, Moodie K, Drummond E, Dutu G, MacManus M, Chua B, Hicks RJ.
    Cancer Imaging; 2014 Apr 22; 14(1):13. PubMed ID: 25608599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 128.